Scandinavian ChemoTech
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar! ChemoTech's Proposed Strategic Changes Accepted by Nasdaq First North
Nasdaq Stockholm shares the Company's assessment that the strategic change, as proposed, does not constitute such a fundamental change in operations as referred to in item 2.5.1 of the Nasdaq First North Growth Market Rulebook.
Nasdaq Stockholm has, however, emphasized that it reserves the right to revise this assessment should circumstances change.
"We are pleased that Nasdaq shares our assessment regarding the proposed changes and that the AGM will be able to decide in May," says Mohan Frick, CEO and Co-founder.